Hi Bhupinder,
Entities that are making a product for the first time available in the market (=placing on the market) are under the MDR/IVDR importers. Making available means supply of a device, other than an investigational device, for distribution, consumption or use on the Union market in the course of a commercial activity, whether in return for payment or free of charge. The distributor (or distributors) is the entity in the supply chain, other than the manufacturer or the importer, that makes a device available on the market, up until the point of putting into service.
Terms like designated distributor are not in the MDR, but are commonly used in logistic supply chains. Any entity that performs the activities above, designated by you or not, is considered either an importer or distributor.
It would be beneficial for these entities (both which are economic operators, let's call the economic partners), to be in contact with you as manufacturer, so they can better/more easier fulfill their regulatory obligations (article 13/14).
Devices needed for the conduct of clinical trail, pre-market - to obtain CE mark or extension of intended purpose, are investigational devices. The terminology above is not relevant for those products and entities.
Devices needed for the conduct of clinical trail, post-market, are to be CE marked and used within intended purpose. Then the terminology above applies again.
------------------------------
Robert van Boxtel
Principal Consultant Medical Device Project B.V.
Alphen a/d Rijn
Netherlands
------------------------------
Original Message:
Sent: 31-Mar-2021 20:38
From: Bhupinder Singh
Subject: EU MDR Importers and Distributors
Hi,
I have a few questions regarding EU MDR.
(1) If the CE marked product is not marketed commercially in EU, do we still need to designate an importer? I think the answer is "NO" as the organization is not distribute their product commercially
(2) Similarly, is a designated distributor required if the products are not commercially distributed?, Same here
(3) Is conducting a clinical trial in Europe considered commercial use or "place in service"? I think it is considered a place of service.
Any feedback or insight would be greatly appreciated.
------------------------------
Bhupinder Singh
QA/RA Manager (RAC)
San Jose CA
United States
------------------------------